• Patient support material

    Access support materials for your patients treated with EXJADE® FCT.

    EXJADE® FCT patient...

  • Medical Resources

    Access Clinical papers and download for your reference.

    New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized...

  • Entresto® (sacubitril/valsartan)

    Indication Heart Failure Entresto® is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection...

  • Diovan® (valsartan)

    DIOVAN ® IS AVAILABLE IN TWO CONVENIENT DOSAGES IN MALAYSIA. About Diovan® Diovan® ® (valsartan) is an orally active, potent and specific angiotensin receptor blocker (ARB). It acts selectively on the AT1 receptor subtype, which is responsible for the...

  • About Diovan®

    Diovan ® (valsartan) is an orally active, potent and specific angiotensin receptor blocker (ARB). It acts selectively on the AT 1 receptor subtype, which is responsible for the known actions of angiotensin II (...

  • Co-Diovan® (valsartan/hydrochlorothiazide)

    Package Insert CO-DIOVAN ® IS AVAILABLE IN THREE CONVENIENT DOSAGES IN MALAYSIA. SEE APPROVED PACKAGE INSERT BEFORE PRESCRIBING. FOR THE MOST UP TO DATE PACKAGE INSERT CLICK HERE. About Co-Diovan® Co-Diovan ® is a combination of Valsartan (an angiotensin...

  • Healthcare Professional Resources

    Counselling Tool

    In many healthcare systems, healthcare professionals are the primary source of direct care for patients. At Novartis, we are committed to support the consultation process between patients and healthcare professionals.

    You may...

page 

Pages

 of  16
×

Ask Speakers

×

Medical Information Request